EGFR and triple-negative breast carcinoma: Recently, we found that dual inhibition of epidermal growth factor receptor (EGFR) and MET kinase activities resulted in the synergistic anti-proliferation effect through downregulation of RPS6 in triple-negative breast cancer (TNBC) cells [21].